These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 13062093)

  • 21. [Psychosedative effect of secale-alkaloids (DHE 45, DHO 180 and hydergin on psychomotor stimulation].
    SOLMS H
    Schweiz Arch Neurol Psychiatr; 1951; 68(1):64-84. PubMed ID: 14876369
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of dihydroergotamine in athyroid and thyroxinized rats.
    SAWYER HK; LIPNER HJ
    Am J Physiol; 1961 Aug; 201():264-6. PubMed ID: 13746953
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of ergotamine, dihydroergotamine and hydergin on the physiology of thyroxin in guinea pig].
    KRONEBERG G; HUTER F; POTZSCH E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1952 Sep; 216(4):344-52. PubMed ID: 12986742
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of ergot alkaloids on venous tonus determined in superficial hand veins in situ].
    Aellig WH
    Cardiology; 1976; 61 suppl 1():302-8. PubMed ID: 975144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The influence of hydergine, tetraethylammonium bromide and blockade of the stellate ganglion on the reactivity of the peripheral veins in cardiac insufficiency].
    LINHART J; PREROVSKY I
    Cardiologia (Basel); 1960; 36():169-80. PubMed ID: 14417254
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative pharmacodynamic study of phergangan, dihydroergotamine and tetraethylammonium].
    GENGOUX P
    Arch Int Pharmacodyn Ther; 1956 Feb; 105(1-2):81-126. PubMed ID: 13314723
    [No Abstract]   [Full Text] [Related]  

  • 27. Factors involved in drug-produced model psychoses.
    FISCHER R
    Experientia; 1954 Oct; 10(10):435-6. PubMed ID: 13220573
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of dihydroergotamine and hydergin on pulmonary arterial pressure in man.
    HALMAGYI D; IVANYI J; FELKAI B; ZSOTER T; TENYI M; SZUCS ZS
    Scand J Clin Lab Invest; 1953; 5(1):85-9. PubMed ID: 13064619
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antagonistic effect of diethylamide of lysergic acid and of methylamphetamine on experimental catalepsy caused by 5-hydroxytryptamine; experimental research on dogs].
    GARELLO L; DOLCE G
    Sist Nerv; 1956; 8(2):61-80. PubMed ID: 13351829
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of dihydroergotamine on epinephrine response in the hind-limb of dogs.
    FINK LD; LOOMIS TA
    Proc Soc Exp Biol Med; 1952 Jul; 80(3):481-3. PubMed ID: 14949091
    [No Abstract]   [Full Text] [Related]  

  • 31. Electrocardiographic abnormalities in noncardiac patients; clinical studies of the effect of some dihydrogenated ergot alkaloids on certain electrocardiographic abnormalities.
    SALOMON MI
    N Y State J Med; 1953 Mar; 53(6):681-6. PubMed ID: 13037073
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study of neurovegetative control of motility of the vibratile cilia of Rana esculenta (experiments with adrenalin, dihydroergotamine, acetylcholine, atropine)].
    RINALDI L
    Boll Mal Orecch Gola Naso; 1960; 78():487-506. PubMed ID: 13741728
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of hydergin on blood pressure].
    LASCH F
    Munch Med Wochenschr; 1952 Jun; 94(26):1325-31. PubMed ID: 12982814
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of dihydroergotamine on cardiac function in a fetus].
    MEDYNSKI M
    Pol Tyg Lek (Wars); 1954 Mar; 9(13):385-8; contd. PubMed ID: 13224399
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological basis of the treatment of orthostatic disorders with ergot alkaloids.
    Stürmer E
    Cardiology; 1976; 61 suppl 1():290-301. PubMed ID: 975143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on tolerance to ganglionic blocking agents in man; reversal of depressor action of quaternary ammonium compounds.
    DONTAS AS; HOOBLER SW
    Circulation; 1954 Dec; 10(6):887-95. PubMed ID: 13209769
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dihydroergotamine and neuroregulation of carbohydrates metabolism in men].
    LUSSO AG
    Minerva Med; 1952 Nov; 43(95):1146-51. PubMed ID: 13025050
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on the hypotensive action of dihydroergokryptine (DHK) and epinephrine-reversal in the dog and cat.
    YUI T; TAKEO Y
    Jpn J Pharmacol; 1957 Sep; 7(1):55-60. PubMed ID: 13513239
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of dihydroergotamine on carbohydrate metabolism].
    SOKOLOWSKA-DEKOWA A
    Acta Physiol Pol; 1952; 3(2):209-22. PubMed ID: 13007483
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anaphylactic reactions in the isolated guinea pig auricle preparation and their influencing by antihistaminics. BOL, dihydroergotamine and reserpine].
    GREEFF K; BENFEY BG; BOKELMANN A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1959; 236():421-34. PubMed ID: 13829189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.